Astrana Health (NASDAQ:ASTH) Updates FY 2024 Earnings Guidance

Astrana Health (NASDAQ:ASTH) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 1.060-1.190 for the period, compared to the consensus earnings per share estimate of 1.310. The company issued revenue guidance of $2.0 billion-$2.0 billion, compared to the consensus revenue estimate of $1.8 billion. Astrana Health also updated its FY24 guidance to $1.06-1.19 EPS.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Stifel Nicolaus lifted their price target on Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. BTIG Research lifted their target price on shares of Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. KeyCorp started coverage on shares of Astrana Health in a research note on Friday, October 11th. They set a “sector weight” rating on the stock. Robert W. Baird boosted their price objective on shares of Astrana Health from $54.00 to $67.00 and gave the stock an “outperform” rating in a research note on Thursday, August 15th. Finally, TD Cowen started coverage on shares of Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 target price on the stock. One analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $62.00.

Astrana Health Price Performance

Shares of NASDAQ:ASTH traded down $0.41 during midday trading on Thursday, reaching $59.08. 279,007 shares of the company were exchanged, compared to its average volume of 197,387. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.62. The business’s fifty day moving average is $55.30 and its two-hundred day moving average is $47.32. Astrana Health has a one year low of $29.63 and a one year high of $63.20. The stock has a market cap of $2.90 billion, a PE ratio of 41.03, a price-to-earnings-growth ratio of 2.08 and a beta of 1.24.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.39 by $0.01. Astrana Health had a net margin of 4.30% and a return on equity of 10.71%. The business had revenue of $486.30 million during the quarter, compared to analyst estimates of $440.68 million. During the same quarter last year, the business earned $0.28 earnings per share. Astrana Health’s quarterly revenue was up 39.7% compared to the same quarter last year. As a group, analysts predict that Astrana Health will post 1.31 earnings per share for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.